BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 16048734)

  • 1. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N; Nakajima T; Hayash K; Nose I; Hashizume Y; Ohyama T; Habukawa M; Kotorii N; Kuwahara H; Maeda H
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):22-9. PubMed ID: 16048734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
    Ozone M; Yagi T; Itoh H; Tamura Y; Inoue Y; Uchimura N; Sasaki M; Shimizu T; Terzano MG; Parrino L
    Pharmacopsychiatry; 2008 May; 41(3):106-14. PubMed ID: 18484552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study on the effects of brotizolam and flurazepam on sleep and performance in the elderly.
    Mamelak M; Csima A; Buck L; Price V
    J Clin Psychopharmacol; 1989 Aug; 9(4):260-7. PubMed ID: 2671059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia.
    Monti JM; Alvariño F; Monti D
    Sleep; 2000 Dec; 23(8):1075-84. PubMed ID: 11145322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM; Lee KA; Scharf MB
    Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality.
    Donath F; Quispe S; Diefenbach K; Maurer A; Fietze I; Roots I
    Pharmacopsychiatry; 2000 Mar; 33(2):47-53. PubMed ID: 10761819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
    Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK; Soubrane C; Roth T
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia.
    Walsh JK; Zammit G; Schweitzer PK; Ondrasik J; Roth T
    Sleep Med; 2006 Mar; 7(2):155-61. PubMed ID: 16260179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of placebo administration on the first-night effect in healthy young volunteers.
    Suetsugi M; Mizuki Y; Yamamoto K; Uchida S; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):839-47. PubMed ID: 17328999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK; Roth T; Randazzo A; Erman M; Jamieson A; Scharf M; Schweitzer PK; Ware JC
    Sleep; 2000 Dec; 23(8):1087-96. PubMed ID: 11145323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
    Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
    Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults.
    Rosenberg R; Caron J; Roth T; Amato D
    Sleep Med; 2005 Jan; 6(1):15-22. PubMed ID: 15680290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
    Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
    Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
    Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem.
    Kryger MH; Steljes D; Pouliot Z; Neufeld H; Odynski T
    Sleep; 1991 Oct; 14(5):399-407. PubMed ID: 1759092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
    Parrino L; Smerieri A; Giglia F; Milioli G; De Paolis F; Terzano MG
    Clin Neuropharmacol; 2008; 31(1):40-50. PubMed ID: 18303490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers.
    Paterson LM; Nutt DJ; Ivarsson M; Hutson PH; Wilson SJ
    J Psychopharmacol; 2009 Jul; 23(5):487-94. PubMed ID: 19351801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.